Intratumoral Hepatic Stellate Cells as a Poor Prognostic Marker and a New Treatment Target for Hepatocellular Carcinoma

• Bin Sun ,

  Contributed equally to this work with: Bin Sun, Xiaofeng Zhang

  Affiliation Molecular Oncology Laboratory, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China

  ⨯
• Xiaofeng Zhang ,

  Contributed equally to this work with: Bin Sun, Xiaofeng Zhang

  Affiliation Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China

  ⨯
• Xianshuo Cheng,

  Affiliation Molecular Oncology Laboratory, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China

  ⨯
• Yu Zhang,

  Affiliation Molecular Oncology Laboratory, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China

  ⨯
• Lei Chen,

  Affiliation Molecular Oncology Laboratory, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China

  ⨯
• Lehua Shi,

  Affiliation Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China

  ⨯
• Zhenyu Liu,

  Affiliation Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China

  ⨯
• Haihua Qian,

  Affiliation Molecular Oncology Laboratory, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China

  ⨯
• Mengchao Wu,

  Affiliations Molecular Oncology Laboratory, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China, Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China

  ⨯
• Zhengfeng Yin

  * E-mail: yinzfk@aliyun.com

  Affiliation Molecular Oncology Laboratory, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China

  ⨯